Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (111-120 of 655) with videos related to

Pageof 66
Sort By:
Anti-Cancer Drugs|July 27, 2000
Determination of camptothecin analogs in biological matrices by high-performance liquid chromatographyW J Loos, P de Bruijn, J Verweij, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineW J Loos, G Stoter, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomasM Van Glabbeke, J Verweij, I Judson, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Possible lack of full cross-resistance of 5HT3 antagonists; a pilot studyM de Boer, R de Wit, G Stoter, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1986
The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapyJ Verweij, M Stuurman, J de Vries, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancerA Dees, J Verweij, W L van Putten, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 4, 2001
Liquid chromatographic determination of ketoconazole, a potent inhibitor of CYP3A4-mediated metabolismP de Bruijn, D F Kehrer, J Verweij, et al.
The Netherlands Journal of Medicine|February 1, 1992
CA 125 in ovarian cancerM E van der Burg, F B Lammes, J Verweij
Veterinary Immunology and Immunopathology|June 8, 2014
Effect of continuous milking on immunoglobulin concentrations in bovine colostrumJ J Verweij, A P Koets, S W F Eisenberg
Cancer Research|February 1, 1990
Radioimmunodetection in rhabdo- and leiomyosarcoma with 111In-anti-myosin monoclonal antibody complexA Planting, J Verweij, P Cox, et al.
Pageof 66

Showing results (111-120 of 655) with videos related to

Sort By:
Pageof 66
Anti-Cancer Drugs|July 27, 2000
Determination of camptothecin analogs in biological matrices by high-performance liquid chromatographyW J Loos, P de Bruijn, J Verweij, et al.
Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urineW J Loos, G Stoter, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomasM Van Glabbeke, J Verweij, I Judson, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Possible lack of full cross-resistance of 5HT3 antagonists; a pilot studyM de Boer, R de Wit, G Stoter, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1986
The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapyJ Verweij, M Stuurman, J de Vries, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancerA Dees, J Verweij, W L van Putten, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 4, 2001
Liquid chromatographic determination of ketoconazole, a potent inhibitor of CYP3A4-mediated metabolismP de Bruijn, D F Kehrer, J Verweij, et al.
The Netherlands Journal of Medicine|February 1, 1992
CA 125 in ovarian cancerM E van der Burg, F B Lammes, J Verweij
Veterinary Immunology and Immunopathology|June 8, 2014
Effect of continuous milking on immunoglobulin concentrations in bovine colostrumJ J Verweij, A P Koets, S W F Eisenberg
Cancer Research|February 1, 1990
Radioimmunodetection in rhabdo- and leiomyosarcoma with 111In-anti-myosin monoclonal antibody complexA Planting, J Verweij, P Cox, et al.
Pageof 66